Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: Nuclear localization of PAD2 and membrane fraction-enriched citrullinated proteins

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 2, 2011, Pages 116-124

  Jang, Byungki ^a   Shin, Hae Young ^a   Choi, Jin Kyu ^a   Nguyen, Du Phuong Thao ^a   Jeong, Byung Hoon ^a   Ishigami, Akihito ^b,c   Maruyama, Naoki ^a,c   Carp, Richard I ^d   Kim, Yong Sun ^a   Choi, Eun Kyoung ^a  

^a Hallym University   (South Korea)

^b TOHO UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Citrullination; Electron microscopy; PAD2; Scrapie; Subcellular fraction

Indexed keywords

CITRULLINATED PROTEIN; PEPTIDYLARGININE DEIMINASE 2; PROTEIN; PROTEIN ARGININE DEIMINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; BRAIN INFECTION; BRAIN MICROSOME; BRAIN MITOCHONDRION; CELL COMPARTMENTALIZATION; CELL FRACTIONATION; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; DEGENERATIVE DISEASE; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GLIA CELL; GOLGI COMPLEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCRAPIE; SCRAPIE AGENT;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BRAIN CHEMISTRY; CELL LINE, TUMOR; CELL MEMBRANE; CELLS, CULTURED; CITRULLINE; HIPPOCAMPUS; HUMANS; HYDROLASES; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; SCRAPIE; SUBCELLULAR FRACTIONS; TRANSFECTION;

EID: 79251595796     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318207559e     Document Type: Article

References (40)

1. Jang B, Kim E, Choi JK, et al. Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: A possible role in pathogenesis. Am J Pathol 2008;173: 1129-42
2. Jang B, Jin JK, Jeon YC, et al. Involvement of peptidylarginine deiminaseYmediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 2010;119: 199-210
3. Ishigami A, Ohsawa T, Hiratsuka M, et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippo-campal extracts from patients with Alzheimer's disease. J Neurosci Res 2005;80:120-28
4. Moscarello MA, Mastronardi FG, Wood DD. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res 2007;32:251-56
5. Vossenaar ER, Zendman AJ, Van Venrooij WJ, et al. PAD, a growing family of citrullinating enzymes: Genes, features and involvement in disease. Bioessays 2003;25:1106-18
6. Tarcsa E, Marekov LN, Mei G, et al. Protein unfolding by peptidylargi-nine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 1996;271: 30709-16
7. Pritzker LB, Joshi S, Gowan JJ, et al. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 2000;39:5374-81
8. Proost P, Loos T, Mortier A, et al. Citrullination of CXCL8 by peptidy-larginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med 2008;205:2085-97
9. Struyf S, Noppen S, Loos T, et al. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and antiYHIV-1 activity via CXCR4. J Immunol 2009;182:666-74
10. Young DS, Meersman F, Oxley D, et al. Effect of enzymatic deimination on the conformation of recombinant prion protein. Biochim Biophys Acta 2009;1794:1123-33
11. Klareskog L, Rönnelid J, Lundberg K, et al. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008;26:651-75
12. Cuthbert GL, Daujat S, Snowden AW, et al. Histone deimination antagonizes arginine methylation. Cell 2004;118:545-53
13. Wang Y, Wysocka J, Sayegh J, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004;306: 279-83
14. Ishigami A, Asaga H, Ohsawa T, et al. Peptidylarginine deiminase Type I, Type II, Type III and Type IV are expressed in rat epidermis. Biomed Res 2001;22:63-65
15. Arita K, Hashimoto H, Shimizu T, et al. Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 2004; 11:777-83
16. Mastronardi FG, Wood DD, Mei J, et al. Increased citrullination of his-tone H3 in multiple sclerosis brain and animal models of demyelination: A role for tumor necrosis factorYinduced peptidylarginine deiminase 4 translocation. J Neurosci 2006;26:11387-96
17. Moscarello MA, Wood DD, Ackerley C, et al. Myelin in multiple sclerosis is developmentally immature. J Clin Invest 1994;94:146-54
18. Bhattacharya SK, Crabb JS, Bonilha VL, et al. Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest Ophthalmol Vis Sci 2006;47:2508-14
19. Musse AA, Li Z, Ackerley CA, et al. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech 2008;1:229-40
20. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998;95:13363-83
21. Aguzzi A, Calella AM. Prions: Protein aggregation and infectious diseases. Physiol Rev 2009;89:1105-52
22. Pamplona R, Naud́i A, Gavín R, et al. Increased oxidation, glycoxidation lipidoxidation of brain proteins in prion disease. Free Rad Biol Med 2008;45:1159-66
23. Giannopoulos PN, Robertson C, Jodoin J, et al. Phosphorylation of prion protein at serine 43 induces prion protein conformational change. J Neurosci 2009;29:8743-51
24. Sc. PLoS One 2009;4:e5633
25. Moody LR, Herbst AJ, Yoo HS, et al. Comparative prion disease gene expression profiling using the prion disease mimetic, cuprizone. Prion 2009;3:99-109
26. Asuni AA, Perry VH, O'Connor V. Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease. Biochem Soc Trans 2010;38:545-51
27. Senshu T, Sato T, Inoue T, et al. Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal Biochem 1992;203:94-100
28. Shimada N, Handa S, Uchida Y, et al. Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain. J Neurosci Res 2010;88:798-806
29. Watanabe K, Akiyama K, Hikichi K, et al. Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues. Biochim Biophys Acta 1988;966:375-83
30. Wood DD, Ackerley CA, Brand B, et al. Myelin localization of peptidylarginine deiminases 2 and 4: Comparison of PAD2 and PAD4 activities. Lab Invest 2008;88:354-64
31. Nakashima K, Hagiwara T, Yamada M. Nuclear localization of pepti-dylarginine deiminase V and histone deimination in granulocytes. J Biol Chem 2002;277:49562-68
32. Li P, Yao H, Zhang Z, et al. Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol 2008;28:4745-58
33. Pizzo P, Pozzan T. MitochondriaYendoplasmic reticulum choreography: Structure and signaling dynamics. Trends Cell Biol 2007;17:511-17
34. Duchen MR, Verkhratsky A, Muallem S. Mitochondria and calcium in health and disease. Cell Calcium 2008;44:1-5
35. Takahara H, Koyama M, Sukawara K. Subcellular location of peptidylarginine deiminase in the mouse brain. Agric Biol Chem 1987;51: 1471-73
36. Moscarello MA, Pritzker L, Mastronardi FG, et al. Peptidylarginine dei-minase: A candidate factor in demyelinating disease. J Neurochem 2002; 81:335-43
37. Mastronardi FG, Moscarello MA. Molecules affecting myelin stability: A novel hypothesis regarding the pathogenesis of multiple sclerosis. J Neurosci Res 2005;80:301-8
38. 2+ dependence by phospholipids and assessment of proposed inhibition by paclitaxel side chains. Biochem Cell Biol 2008;86:437-47
39. Andréoletti O, Berthon P, Marc D, et al. Early accumulation of PrP(Sc) in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J Gen Virol 2000;81:3115-26
40. Tatzelt J, Groth DF, Torchia M, et al. Kinetics of prion protein accumulation in the CNS of mice with experimental scrapie. J Neuropathol Exp Neurol 1999;58:1244-49